CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
1,992.00
-83.00 (-4.00%)
Jun 27, 2025, 3:30 PM KST
CMG Pharmaceutical Revenue
CMG Pharmaceutical had revenue of 20.63B KRW in the quarter ending March 31, 2025, a decrease of -9.59%. This brings the company's revenue in the last twelve months to 96.91B, up 3.35% year-over-year. In the year 2024, CMG Pharmaceutical had annual revenue of 99.10B with 5.53% growth.
Revenue (ttm)
96.91B
Revenue Growth
+3.35%
P/S Ratio
3.14
Revenue / Employee
423.19M
Employees
229
Market Cap
304.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 99.10B | 5.19B | 5.53% |
Dec 31, 2023 | 93.91B | 11.71B | 14.25% |
Dec 31, 2022 | 82.20B | 23.57B | 40.21% |
Dec 31, 2019 | 58.62B | 8.76B | 17.56% |
Dec 31, 2018 | 49.86B | 8.33B | 20.05% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |